Recombinant promoter system specifically inducing high level of gene expression after t cell activation
AssigneeXuzhou Medical University
InventorsHONGWEI DU, FEI LI, ZHUDI LI, CHEN WANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeXuzhou Medical University
InventorsHONGWEI DU, FEI LI, ZHUDI LI, CHEN WANG
Estimating the term…
Provided is a recombinant promoter system specifically inducing gene expression after T cell activation. Also provided is a new T cell activation-induced recombinant promoter constructed by modifying and optimizing GM-CSF, IFNg and IL2 promoters. When CAR-T cells are activated, the recombinant promoter can efficiently induce the expression of downstream genes, with the activity thereof being superior to that of a traditional NFAT-responsive promoter constructed based on a binding sequence of a nuclear factor of activated T cells. Further provided are a CAR-T cell comprising the T cell activation-induced recombinant promoter and the use thereof.
A genetically modified promoter element, where the promoter element is a T cell activation induced promoter, and the promoter element has a fragment derived from a promoter selected from the group consisting of:
Dependencies are inferred from the claim text.